Inactive Instrument

Calendar Anavex Life Sciences Corp OTC Bulletin Board

Equities

AVXL

US0327971026

End-of-day quote OTC Bulletin Board
- USD - Intraday chart for Anavex Life Sciences Corp

Chart calendar Anavex Life Sciences Corp

97.4TMf66MF3TPGycfb3Cy1U7S_hjsAgtX2iHzdOnOLsOA.jnp7kvJkmXWRj_ah62bGIc33wQJItpyl3EunVhns5oamflDbm1KZRqebng~3eb7c2e19bf2136e3449ed9e1c2f38d9

Upcoming events on Anavex Life Sciences Corp

2024-05-08 Q2 2024 Earnings Release (Projected)
2024-08-07 Q3 2024 Earnings Release (Projected)
2024-11-24 Q4 2024 Earnings Release (Projected)
2025-02-05 Q1 2025 Earnings Release (Projected)

Past events on Anavex Life Sciences Corp

2024-04-18 01:30 pm Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference
2024-04-08 08:45 am Needham Healthcare Conference
2024-03-04 01:30 pm TD Cowen Health Care Conference
2024-02-07 08:30 am Q1 2024 Earnings Call
2024-02-07 07:30 am Q1 2024 Earnings Release
2024-01-11 01:30 pm JPMorgan Healthcare Conference
2023-11-27 08:30 am Q4 2023 Earnings Call
2023-11-27 08:00 am Q4 2023 Earnings Release
2023-08-08 08:30 am Q3 2023 Earnings Call
2023-08-08 07:30 am Q3 2023 Earnings Release
2023-08-07 12:30 pm BTIG Virtual Biotechnology Conference
2023-06-26 07:00 am H.C. Wainwright Neuropsychiatry Conference - Fireside Chat
2023-05-22 Annual General Meeting
2023-05-09 08:30 am Q2 2023 Earnings Call
2023-05-09 07:30 am Q2 2023 Earnings Release
2023-05-02 09:30 am H.C. Wainwright BioConnect Investor Conference - Fireside Chat
2023-04-17 08:00 am Needham Healthcare Conference
2023-02-07 08:30 am Q1 2023 Earnings Call
2023-02-07 07:00 am Q1 2023 Earnings Release
2023-01-12 11:15 am JP Morgan Healthcare Conference

Annual results

Fiscal PeriodSeptember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00

EBITDA
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
-51,0
-48,0
-6.22%
-55,8
-57,0
2.18%

0,00

EBIT
Million USD
Released
Forecast
Spread
0,00
0,00
-
-31,1
-31,9
2.39%
-42,0
-40,8
-2.88%
-51,0
-48,8
-4.38%
-55,8
-56,6
1.41%

-52,8

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
0,00
0,00
-
-26,3
-29,8
11.86%
-37,6
-36,6
-2.72%
-47,6
-48,1
0.96%
-47,5
-50,7
6.3%

-46,5

Net income
Million USD
Released
Forecast
Spread
0,00
0,00
-
-26,3
-29,5
10.81%
-37,9
-37,1
-2.26%
-48,0
-47,8
-0.37%
-47,5
-50,7
6.36%

-46,6

EPS
USD
Released
Forecast
Spread
-0,54
-0,62
12.9%
-0,45
-0,51
11.76%
-0,54
-0,54
-0.93%
-0,62
-0,62
0%
-0,60
-0,64
5.51%

-0,57

Announcement Date16/12/1928/12/2024/11/2128/11/2227/11/23-

Quarterly results

Fiscal PeriodSeptember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00


0,00


0,00

EBIT
Million USD
Released
Forecast
Spread
-11,7
-12,6
6.98%
-11,5
-13,0
11.48%
-12,5
-13,1
4.79%
-15,3
-13,1
-16.7%
-15,4
-15,0
-2.39%
-14,2
-15,0
5.41%
-13,5
-14,0
3.35%
-12,7
-13,0
2.67%




-12,0


-13,5


-16,0

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-10,9
-12,4
12.28%
-10,4
-12,7
17.72%
-12,3
-12,9
4.85%
-14,1
-13,0
-8.25%
-13,0
-15,0
13.44%
-13,1
-14,1
7.4%
-11,2
-13,3
15.5%
-10,2
-12,1
15.61%




-10,6


-12,4


-15,0

Net income
Million USD
Released
Forecast
Spread
-10,9
-12,6
13.52%
-10,4
-13,0
19.69%
-12,4
-12,8
3.41%
-14,3
-13,4
-6.93%
-13,0
-15,0
13.57%
-13,1
-14,1
7.04%
-11,3
-13,3
15.19%
-10,1
-12,1
16.14%




-10,6


-12,4


-15,0

EPS
USD
Released
Forecast
Spread
-0,14
-0,16
12.5%
-0,14
-0,17
17.65%
-0,16
-0,17
3.03%
-0,18
-0,17
-5.88%
-0,17
-0,19
10.53%
-0,17
-0,18
5.56%
-0,14
-0,17
17.65%
-0,12
-0,15
20%
-0,11
-0,15
26.67%

-0,13


-0,15


-0,18

Announcement Date09/02/2210/05/2209/08/2228/11/2207/02/2309/05/2308/08/2327/11/2307/02/24---
  1. Stock Market
  2. Equities
  3. AVXL Stock
  4. AVXL Stock
  5. Calendar Anavex Life Sciences Corp